Vestal Point Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,888
Closed -$214K 74
2025
Q1
$214K Buy
+14,888
New +$214K 0.02% 63